Non-Hodgkin's lymphomas clinical practice guidelines in oncology

Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, John C. Byrd, Myron S. Czuczman, Luis Fayad, Andres Forero, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Mark S. Kaminski, Youn H. Kim, Ann S. Lacasce, Tariq I. Mughal, Auyporn Nademanee, Pierluigi Porcu & 10 others Oliver Press, Leonard Prosnitz, Nashitha Reddy, Mitchell R. Smith, Lubomir Sokol, Lode Swinnen, Julie Marie Vose, William G. Wierda, Joachim Yahalom, Furhan Yunus

Research output: Contribution to journalReview article

159 Citations (Scopus)

Abstract

Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval.

Original languageEnglish (US)
Pages (from-to)288-334
Number of pages47
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number3
DOIs
StatePublished - Jan 1 2010

Fingerprint

Practice Guidelines
Non-Hodgkin's Lymphoma
Guidelines
Adult T Cell Leukemia Lymphoma
Lymphoproliferative Disorders
Lymphoma
B-Lymphocytes
Therapeutics
Lymphocytes
T-Lymphocytes
Population

Keywords

  • Chronic lymphocytic leukemia
  • Cutaneous T-cell lymphoma
  • Diagnosis
  • Diffuse large B-cell lymphoma
  • Follicular lymphoma
  • Hematopathology
  • Immunohistochemistry
  • Lymphoma pathology
  • Mantle cell lymphoma
  • Marginal zone lymphoma
  • Mucosa-associated lymphoid tissue lymphoma
  • Mycosis fungoides
  • NCCN clinical practice guidelines
  • Non-Hodgkin's lymphoma
  • Peripheral
  • Staging evaluation
  • Sézary syndrome
  • T-cell lymphoma
  • Treatment
  • Treatment guidelines

ASJC Scopus subject areas

  • Oncology

Cite this

Zelenetz, A. D., Abramson, J. S., Advani, R. H., Babis Andreadis, C., Byrd, J. C., Czuczman, M. S., ... Yunus, F. (2010). Non-Hodgkin's lymphomas clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 8(3), 288-334. https://doi.org/10.6004/jnccn.2010.0021

Non-Hodgkin's lymphomas clinical practice guidelines in oncology. / Zelenetz, Andrew D.; Abramson, Jeremy S.; Advani, Ranjana H.; Babis Andreadis, C.; Byrd, John C.; Czuczman, Myron S.; Fayad, Luis; Forero, Andres; Glenn, Martha J.; Gockerman, Jon P.; Gordon, Leo I.; Harris, Nancy Lee; Hoppe, Richard T.; Horwitz, Steven M.; Kaminski, Mark S.; Kim, Youn H.; Lacasce, Ann S.; Mughal, Tariq I.; Nademanee, Auyporn; Porcu, Pierluigi; Press, Oliver; Prosnitz, Leonard; Reddy, Nashitha; Smith, Mitchell R.; Sokol, Lubomir; Swinnen, Lode; Vose, Julie Marie; Wierda, William G.; Yahalom, Joachim; Yunus, Furhan.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 8, No. 3, 01.01.2010, p. 288-334.

Research output: Contribution to journalReview article

Zelenetz, AD, Abramson, JS, Advani, RH, Babis Andreadis, C, Byrd, JC, Czuczman, MS, Fayad, L, Forero, A, Glenn, MJ, Gockerman, JP, Gordon, LI, Harris, NL, Hoppe, RT, Horwitz, SM, Kaminski, MS, Kim, YH, Lacasce, AS, Mughal, TI, Nademanee, A, Porcu, P, Press, O, Prosnitz, L, Reddy, N, Smith, MR, Sokol, L, Swinnen, L, Vose, JM, Wierda, WG, Yahalom, J & Yunus, F 2010, 'Non-Hodgkin's lymphomas clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 3, pp. 288-334. https://doi.org/10.6004/jnccn.2010.0021
Zelenetz AD, Abramson JS, Advani RH, Babis Andreadis C, Byrd JC, Czuczman MS et al. Non-Hodgkin's lymphomas clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2010 Jan 1;8(3):288-334. https://doi.org/10.6004/jnccn.2010.0021
Zelenetz, Andrew D. ; Abramson, Jeremy S. ; Advani, Ranjana H. ; Babis Andreadis, C. ; Byrd, John C. ; Czuczman, Myron S. ; Fayad, Luis ; Forero, Andres ; Glenn, Martha J. ; Gockerman, Jon P. ; Gordon, Leo I. ; Harris, Nancy Lee ; Hoppe, Richard T. ; Horwitz, Steven M. ; Kaminski, Mark S. ; Kim, Youn H. ; Lacasce, Ann S. ; Mughal, Tariq I. ; Nademanee, Auyporn ; Porcu, Pierluigi ; Press, Oliver ; Prosnitz, Leonard ; Reddy, Nashitha ; Smith, Mitchell R. ; Sokol, Lubomir ; Swinnen, Lode ; Vose, Julie Marie ; Wierda, William G. ; Yahalom, Joachim ; Yunus, Furhan. / Non-Hodgkin's lymphomas clinical practice guidelines in oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2010 ; Vol. 8, No. 3. pp. 288-334.
@article{9432e704f98540edabcc4fbc658cdf06,
title = "Non-Hodgkin's lymphomas clinical practice guidelines in oncology",
abstract = "Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval.",
keywords = "Chronic lymphocytic leukemia, Cutaneous T-cell lymphoma, Diagnosis, Diffuse large B-cell lymphoma, Follicular lymphoma, Hematopathology, Immunohistochemistry, Lymphoma pathology, Mantle cell lymphoma, Marginal zone lymphoma, Mucosa-associated lymphoid tissue lymphoma, Mycosis fungoides, NCCN clinical practice guidelines, Non-Hodgkin's lymphoma, Peripheral, Staging evaluation, S{\'e}zary syndrome, T-cell lymphoma, Treatment, Treatment guidelines",
author = "Zelenetz, {Andrew D.} and Abramson, {Jeremy S.} and Advani, {Ranjana H.} and {Babis Andreadis}, C. and Byrd, {John C.} and Czuczman, {Myron S.} and Luis Fayad and Andres Forero and Glenn, {Martha J.} and Gockerman, {Jon P.} and Gordon, {Leo I.} and Harris, {Nancy Lee} and Hoppe, {Richard T.} and Horwitz, {Steven M.} and Kaminski, {Mark S.} and Kim, {Youn H.} and Lacasce, {Ann S.} and Mughal, {Tariq I.} and Auyporn Nademanee and Pierluigi Porcu and Oliver Press and Leonard Prosnitz and Nashitha Reddy and Smith, {Mitchell R.} and Lubomir Sokol and Lode Swinnen and Vose, {Julie Marie} and Wierda, {William G.} and Joachim Yahalom and Furhan Yunus",
year = "2010",
month = "1",
day = "1",
doi = "10.6004/jnccn.2010.0021",
language = "English (US)",
volume = "8",
pages = "288--334",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "3",

}

TY - JOUR

T1 - Non-Hodgkin's lymphomas clinical practice guidelines in oncology

AU - Zelenetz, Andrew D.

AU - Abramson, Jeremy S.

AU - Advani, Ranjana H.

AU - Babis Andreadis, C.

AU - Byrd, John C.

AU - Czuczman, Myron S.

AU - Fayad, Luis

AU - Forero, Andres

AU - Glenn, Martha J.

AU - Gockerman, Jon P.

AU - Gordon, Leo I.

AU - Harris, Nancy Lee

AU - Hoppe, Richard T.

AU - Horwitz, Steven M.

AU - Kaminski, Mark S.

AU - Kim, Youn H.

AU - Lacasce, Ann S.

AU - Mughal, Tariq I.

AU - Nademanee, Auyporn

AU - Porcu, Pierluigi

AU - Press, Oliver

AU - Prosnitz, Leonard

AU - Reddy, Nashitha

AU - Smith, Mitchell R.

AU - Sokol, Lubomir

AU - Swinnen, Lode

AU - Vose, Julie Marie

AU - Wierda, William G.

AU - Yahalom, Joachim

AU - Yunus, Furhan

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval.

AB - Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval.

KW - Chronic lymphocytic leukemia

KW - Cutaneous T-cell lymphoma

KW - Diagnosis

KW - Diffuse large B-cell lymphoma

KW - Follicular lymphoma

KW - Hematopathology

KW - Immunohistochemistry

KW - Lymphoma pathology

KW - Mantle cell lymphoma

KW - Marginal zone lymphoma

KW - Mucosa-associated lymphoid tissue lymphoma

KW - Mycosis fungoides

KW - NCCN clinical practice guidelines

KW - Non-Hodgkin's lymphoma

KW - Peripheral

KW - Staging evaluation

KW - Sézary syndrome

KW - T-cell lymphoma

KW - Treatment

KW - Treatment guidelines

UR - http://www.scopus.com/inward/record.url?scp=77949822338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949822338&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2010.0021

DO - 10.6004/jnccn.2010.0021

M3 - Review article

VL - 8

SP - 288

EP - 334

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 3

ER -